DEBORAH FERRINGTON
Chief Scientific Officer
Doheny Eye Institute
Deborah Ferrington, PhD, is Doheny Eye Institute’s chief scientific Officer and holds the Stephen J. Ryan – Arnold and Mabel Beckman Foundation endowed presidential chair. Prior to assuming her role as CSO in May 2022, she had more than 20 years of experience in academic research as professor and Elaine and Robert Larson Endowed Vision research chair and director of research in the Department of Ophthalmology and Visual Neurosciences at the University of Minnesota, Twin Cities.
Dr. Ferrington is internationally recognized for her groundbreaking research on age-related macular degeneration (AMD), the leading cause of blindness among the elderly. It is estimated that 290 million individuals will suffer from AMD by 2040, which imposes heavy burdens on healthcare systems worldwide. Dr. Ferrington’s research could eventually lead to a “personalized medicine” approach for the treatment of AMD, which would be a breakthrough in treating this prevalent disease with limited effective therapies.
